www.fdanews.com/articles/97955-micromet-sticks-to-tough-cancer-target
Micromet Sticks to Tough Cancer Target
August 31, 2007
Micromet is sticking to its research into cell adhesion antibodies to treat breast cancer and other tumours, hoping it will have more luck than GlaxoSmithKline and Centocor’s failed attempt.
BioPharma-Reporter.com